Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism — Stella

Home/Primary Aldosteronism/

View on ClinicalTrials.gov

Recruiting

Back to Primary Aldosteronism trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing

Key details

Phase

Early testing / Safety & dosing

Sponsor

Peking Union Medical College Hospital

Enrollment target

~150 participants

Started

December 2023

Primary completion

May 2026

Age range

18 Years – 80 Years

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.